BioCentury
ARTICLE | Clinical News

TRO40303: Phase I started

October 11, 2010 7:00 AM UTC

Trophos began a placebo-controlled Phase I trial to evaluate single-escalating doses of IV TRO40303 in 64 healthy volunteers. ...